Overview

AL-54478 Proof of Concept Study

Status:
Completed

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess the safety and efficacy of AL-54478 0.005% compared with Latanoprost 0.005% and AL-54478 Vehicle in patients with open-angle glaucoma or ocular hypertension.

Phase:

Phase 2

Details

Lead Sponsor:

Alcon Research

Treatments:

Latanoprost